News, events, and resources
Nov 21, 2025
Strategies for Antibody-Drug Conjugates Bioanalysis
Antibody-drug conjugates (ADCs) bioanalysis requires robust methods to track antibodies, payloads, and drug-to-antibody ratio changes in ...
Oct 9, 2025
Improving the Sensitivity and Drug Tolerance of a NAb Assay by Optimizing MRD
Optimizing the Minimal Required Dilution (MRD) in a cLBA NAb assay improved sensitivity fourfold and drug tolerance fivefold, enhancing ...
Sep 18, 2025
Representative Pooled Matrix Selection is Critical in ADA Assays
Our scientists developed a strategy to reduce false positives and improve the reliability of ADA assays
Sep 18, 2025
A Generic LC-MS/MS Solution for ADC PK Bioanalysis
Our experts developed a highly sensitive and specific workflow to quantify total antibodies, conjugated payload, and free payload in ...
Sep 18, 2025
An immunogenicity analysis strategy to reduce the interference of soluble target proteins
Our experts established a bioanalytical strategy to eliminate false positive signals caused by soluble drug targets in ADA assays, ...
Sep 18, 2025
Receptor occupancy of antibody drug measured by flow cytometry
Our experts developed a PD-1 receptor occupancy (RO) assay to monitor drug–target interactions and support pharmacodynamic evaluation in ...
Sep 17, 2025
Dr. Lorin K. Roskos Appointed Chief Scientific Officer and Head of Quantitative Clinical Pharmacology
Dr. Lorin K. Roskos joins CBS as CSO & Head of Quantitative Clinical Pharmacology (QCP), bringing 30+ years of R&D expertise to ...
Sep 16, 2025
A LC-MS/MS Method for Oligonucleotide PK Bioanalysis
In this case study our experts developed an LC-MS/MS method for oligonucleotide pharmacokinetic (PK) analysis in early-phase clinical ...
Sep 16, 2025
Immunophenotyping to identify peripheral lymphocyte subsets
Discover how our experts developed FACS-based immunophenotyping method to monitor T and NK cell populations in solid tumor treatment ...
Sep 16, 2025
Sample Pretreatment Approaches to Improve Drug Tolerance in ADA Assay
In this case study our experts developed an ADA assay for a prodrug where traditional acid dissociation alone could not meet tolerance ...
Strategies for Antibody-Drug Conjugates Bioanalysis
Antibody-drug conjugates (ADCs) bioanalysis requires robust methods to track antibodies, payloads, and drug-to-antibody ratio changes in ...
Improving the Sensitivity and Drug Tolerance of a NAb Assay by Optimizing MRD
Optimizing the Minimal Required Dilution (MRD) in a cLBA NAb assay improved sensitivity fourfold and drug tolerance fivefold, enhancing ...
Representative Pooled Matrix Selection is Critical in ADA Assays
Our scientists developed a strategy to reduce false positives and improve the reliability of ADA assays
A Generic LC-MS/MS Solution for ADC PK Bioanalysis
Our experts developed a highly sensitive and specific workflow to quantify total antibodies, conjugated payload, and free payload in ...
An immunogenicity analysis strategy to reduce the interference of soluble target proteins
Our experts established a bioanalytical strategy to eliminate false positive signals caused by soluble drug targets in ADA assays, ...
Receptor occupancy of antibody drug measured by flow cytometry
Our experts developed a PD-1 receptor occupancy (RO) assay to monitor drug–target interactions and support pharmacodynamic evaluation in ...
A LC-MS/MS Method for Oligonucleotide PK Bioanalysis
In this case study our experts developed an LC-MS/MS method for oligonucleotide pharmacokinetic (PK) analysis in early-phase clinical ...
Immunophenotyping to identify peripheral lymphocyte subsets
Discover how our experts developed FACS-based immunophenotyping method to monitor T and NK cell populations in solid tumor treatment ...
Sample Pretreatment Approaches to Improve Drug Tolerance in ADA Assay
In this case study our experts developed an ADA assay for a prodrug where traditional acid dissociation alone could not meet tolerance ...
Dr. Lorin K. Roskos Appointed Chief Scientific Officer and Head of Quantitative Clinical Pharmacology
Dr. Lorin K. Roskos joins CBS as CSO & Head of Quantitative Clinical Pharmacology (QCP), bringing 30+ years of R&D expertise to ...
